G Puliani
Overview
Explore the profile of G Puliani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
47
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sada V, Puliani G, Feola T, Pirchio R, Pofi R, Sesti F, et al.
J Endocrinol Invest
. 2023 Oct;
47(4):777-793.
PMID: 37891382
Purpose: Tall stature is defined as height greater than the threshold of more than 2 standard deviations above the average population height for age, sex, and ethnicity. Many studies have...
2.
Sesti F, Puliani G, Feola T, Campolo F, Sciarra F, Hasenmajer V, et al.
Endocrine
. 2022 Dec;
80(1):221-230.
PMID: 36509928
Purpose: The immune environment represents a new, but little explored, tool for understanding neuroendocrine neoplasms (NENs) behavior. An immunosuppressed microenvironment is hypothesized to promote NENs progression. A missing profiling of...
3.
Feola T, Pirchio R, Puliani G, Pofi R, Crocco M, Sada V, et al.
J Endocrinol Invest
. 2022 Aug;
46(1):181-188.
PMID: 36001286
Background: Sellar/parasellar lesions have been studied in the adult and paediatric age range, but during the transition age their epidemiology, clinical manifestations, management and treatment outcomes have been poorly investigated....
4.
Feola T, Puliani G, Sesti F, Modica R, Centello R, Minotta R, et al.
J Endocrinol Invest
. 2022 Jan;
45(4):849-857.
PMID: 35040099
Purpose: Risk factors for sporadic GEP-NENs are still not well defined. To identify the main clinical risk factors represents the aim of this study performed by three Italian referral centers...
5.
Gallo M, Adinolfi V, Barucca V, Prinzi N, Renzelli V, Barrea L, et al.
Rev Endocr Metab Disord
. 2020 Oct;
22(4):681-702.
PMID: 33025385
Obesity, whose prevalence is pandemic and continuing to increase, is a major preventable and modifiable risk factor for diabetes and cardiovascular diseases, as well as for cancer. Furthermore, epidemiological studies...